Found: 77
Select item for more details and to access through your institution.
Dural Metastasis in Breast Cancer: MRI-Based Morphological Subtypes and Their Clinical Implications.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1105, doi. 10.4143/crt.2024.138
- By:
- Publication type:
- Article
Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography—a prospective study.
- Published in:
- European Radiology, 2022, v. 32, n. 2, p. 815, doi. 10.1007/s00330-021-08196-y
- By:
- Publication type:
- Article
A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
In Vitro Chemoresponse Assay Based on the Intrinsic Subtypes in Breast Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 9, p. 880, doi. 10.1093/jjco/hyu123
- By:
- Publication type:
- Article
In Vitro Chemoresponse Assay Based on the Intrinsic Subtypes in Breast Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 7, p. 624, doi. 10.1093/jjco/hyu057
- By:
- Publication type:
- Article
Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 12, p. 23658, doi. 10.3390/ijms141223685
- By:
- Publication type:
- Article
Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 193, n. 3, p. 637, doi. 10.1007/s10549-022-06601-8
- By:
- Publication type:
- Article
Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 165, doi. 10.1007/s10549-021-06193-9
- By:
- Publication type:
- Article
Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 3, p. 797, doi. 10.1007/s10549-020-05907-9
- By:
- Publication type:
- Article
A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 157, doi. 10.1007/s10549-018-5038-x
- By:
- Publication type:
- Article
Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 295, doi. 10.1007/s10549-018-4842-7
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25540-4
- By:
- Publication type:
- Article
Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1--2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.936148
- By:
- Publication type:
- Article
Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1182820
- By:
- Publication type:
- Article
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 3325, doi. 10.2147/DMSO.S269237
- By:
- Publication type:
- Article
Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 13, p. 4294, doi. 10.1245/s10434-019-07819-5
- By:
- Publication type:
- Article
Choosing Wisely: The Korean Perspective and Launch of the 'Right Decision in Cancer Care' Initiative.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 3, p. 655, doi. 10.4143/crt.2020.221
- By:
- Publication type:
- Article
Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 3, p. 625, doi. 10.4143/crt.2017.089
- By:
- Publication type:
- Article
Prospective Evaluation of the Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Negative Axillary Conversion after Neoadjuvant Chemotherapy.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 1, p. 26, doi. 10.4143/crt.2013.208
- By:
- Publication type:
- Article
[18F]-Fluorodeoxyglucose Positron Emission Tomography Can Contribute to Discriminate Patients with Poor Prognosis in Hormone Receptor-Positive Breast Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0105905
- By:
- Publication type:
- Article
The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063510
- By:
- Publication type:
- Article
Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 11, p. e2243935, doi. 10.1001/jamanetworkopen.2022.43935
- By:
- Publication type:
- Article
Author Correction: Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00424-y
- By:
- Publication type:
- Article
Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00384-3
- By:
- Publication type:
- Article
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61640-z
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1254, doi. 10.3390/cancers16071254
- By:
- Publication type:
- Article
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 842, doi. 10.3390/cancers16040842
- By:
- Publication type:
- Article
Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer—The BRAIN Study.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 774, doi. 10.3390/cancers16040774
- By:
- Publication type:
- Article
Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 377, doi. 10.3390/cancers16020377
- By:
- Publication type:
- Article
YAP1 Expression in HR+HER2− Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5034, doi. 10.3390/cancers15205034
- By:
- Publication type:
- Article
Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 4971, doi. 10.3390/cancers14204971
- By:
- Publication type:
- Article
SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133042
- By:
- Publication type:
- Article
The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6205, doi. 10.3390/cancers13246205
- By:
- Publication type:
- Article
Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4654, doi. 10.3390/cancers13184654
- By:
- Publication type:
- Article
Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4003, doi. 10.3390/cancers13164003
- By:
- Publication type:
- Article
Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1806, doi. 10.3390/cancers13081806
- By:
- Publication type:
- Article
Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1896, doi. 10.3390/cancers12071896
- By:
- Publication type:
- Article
Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 497, doi. 10.3390/cancers12020497
- By:
- Publication type:
- Article
The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
- Published in:
- PLoS ONE, 2021, v. 16, n. 5, p. 1, doi. 10.1371/journal.pone.0250986
- By:
- Publication type:
- Article
Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 8, p. e2330961, doi. 10.1001/jamanetworkopen.2023.30961
- By:
- Publication type:
- Article
Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1409, doi. 10.1002/cam4.5022
- By:
- Publication type:
- Article
In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 2, p. 121, doi. 10.3857/roj.2017.00150
- By:
- Publication type:
- Article
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.689587
- By:
- Publication type:
- Article
High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.609743
- By:
- Publication type:
- Article
Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 6, p. 40, doi. 10.1186/s13058-014-0502-y
- By:
- Publication type:
- Article
High A20 expression negatively impacts survival in patients with breast cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221721
- By:
- Publication type:
- Article
Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis.
- Published in:
- Breast Care, 2020, v. 15, n. 4, p. 408, doi. 10.1159/000503847
- By:
- Publication type:
- Article